BARABINO, LUCA

BARABINO, LUCA  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.01 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Editore
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis 1-gen-2024 Murru, Roberta; Galitzia, Andrea; Barabino, Luca; Presicci, Roberta; La Nasa, Giorgio; Caocci, Giovanni ANNALS OF HEMATOLOGY -
Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy 1-gen-2023 Galitzia, A; Murru, R; Caocci, G; Barabino, L; Azzena, A; Licheri, V M; Greco, M; La Nasa, G EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES -
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation 1-gen-2022 Barabino, L; Galitzia, A; Murru, R; Caocci, G; Targhetta, C; Greco, M; Angioni, G; Mulas, O; Vacca, A; Piras, E; Frau, V; Costa, A; La Nasa, G EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES -
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine 1-gen-2022 Galitzia, Andrea; Barabino, Luca; Murru, Roberta; Caocci, Giovanni; Greco, Marianna; Angioni, Giancarlo; Mulas, Olga; Oppi, Sara; Massidda, Stefania; Costa, Alessandro; La Nasa, Giorgio VACCINES -
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis 1-gen-2022 Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galizia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio ANNALS OF HEMATOLOGY -
Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib? 1-gen-2021 Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galitzia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio BLOOD -